Uremia and mechanisms of aluminium neurotoxicity: an overview.
Savazzi
G M
GM
D000535:Aluminum / Q000009:adverse effects*; D000818:Animals; D002118:Calcium / Q000502:physiology; D002147:Calmodulin / Q000187:drug effects; D002493:Central Nervous System Diseases / Q000139:chemically induced*; D003704:Dementia / Q000139:chemically induced*; D015312:Hemodialysis Solutions; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy; D009417:Nerve Tissue / Q000187:drug effects; D018377:Neurotransmitter Agents / Q000037:antagonists & inhibitors; D006435:Renal Dialysis / Q000009:adverse effects*; D009435:Synaptic Transmission / Q000187:drug effects
D002147:Calmodulin; D015312:Hemodialysis Solutions; D018377:Neurotransmitter Agents; D000535:Aluminum; D002118:Calcium